A-shares open · 港股交易中 Quotes 行情 · 28 Sep 09:34 CST
28 Sep 2026 · 09:34 CST Terminal Access 终端入口 →
688266.SH上海证券交易所 · 科创板 STAR

Zelgen 泽璟制药

Chemical Pharmaceuticals 化学制药
¥110.51+¥1.56 · +1.43%Live 实时 · 28 Sep 2026 · 09:34 CST · CNY
Open 开盘
¥108.95
High 最高
¥111.97
Low 最低
¥108.94
Prev Close 昨收
¥108.95
Volume 成交量
36.8万股
Turnover 成交额
¥4,083.4万
Mkt Cap 总市值
¥293亿
P/E 市盈率
53.2×
Recent Activity 近期动态All Filings 全部公告 →

5 broker reports from 4 firms since 31 May 2026, the latest on 10 Aug 2026.
自 31 May 2026 起有 5 份研报,来自 4 家券商,最新一份见于 10 Aug 2026。

Price History 价格走势

5 sessions 个交易日, 21 Sep to 28 Sep 2026 · Live one-minute prices · High 最高 ¥121.37 · Low 最低 ¥108.54 · +0.79% on the previous close of ¥108.95
110.0112.5115.0117.5120.0
Volume 成交量
19.1万
21 Sep22 Sep23 Sep24 Sep28 Sep

Against Its Own History 与自身历史比较

53.2×
Median 中值 54.3× · Range 区间 52.6× to 56.1× · 2 periods 期
17.00×
Median 中值 12.48× · Range 区间 6.78× to 26.04× · 20 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥116.66¥2.0856.1×¥6.5017.95×
31 Mar 2026 一季报¥98.80¥1.8852.6×¥6.4715.27×
31 Dec 2025 年报¥92.70−¥0.62—¥4.0822.71×
30 Sep 2025 三季报¥113.01−¥0.50—¥4.3426.04×
30 Jun 2025 中报¥107.51−¥0.55—¥4.4424.19×
31 Mar 2025 一季报¥99.74−¥0.48—¥4.6321.53×
31 Dec 2024 年报¥62.31−¥0.52—¥4.7413.15×
30 Sep 2024 三季报¥68.65−¥0.66—¥4.9213.94×
30 Jun 2024 中报¥54.22−¥0.88—¥5.929.16×
31 Mar 2024 一季报¥53.90−¥1.00—¥6.028.95×
31 Dec 2023 年报¥52.94−¥1.09—¥6.178.58×
30 Sep 2023 三季报¥46.63−¥1.19—¥6.547.13×
30 Jun 2023 中报¥46.55−¥1.34—¥6.876.78×
31 Mar 2023 一季报¥49.41−¥1.65—¥2.9516.73×
31 Dec 2022 年报¥41.70−¥1.91—¥3.1613.18×
30 Sep 2022 三季报¥33.85−¥2.18—¥3.519.63×
30 Jun 2022 中报¥35.89−¥2.17—¥3.969.06×
31 Mar 2022 一季报¥36.14−¥2.05—¥4.458.12×
31 Dec 2021 年报¥58.80−¥1.88—¥4.9811.80×
30 Sep 2021 三季报¥65.30−¥1.60—¥5.6211.63×

Consensus Forward EPS 机构预测每股收益

Fiscal Year 年度EPS Median 中值Range 区间Brokers 机构数Forward P/E 预测市盈率
2026¥1.85¥1.33 to ¥2.04459.6×
2027¥1.61¥0.91 to ¥2.44468.4×
2028¥2.34¥1.10 to ¥3.63447.2×
Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA